May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Effect of EPO on isolated rat retina ERG b–wave amplitude.
Author Affiliations & Notes
  • M. Doly
    Laboratoire de Biophysique, Schools of Medicine and Pharmacy, Clermont Ferrand, France
  • B. Bonhomme
    Laboratoire de Biophysique, Schools of Medicine and Pharmacy, Clermont Ferrand, France
  • C. Gamez
    Laboratoire de Biophysique, Schools of Medicine and Pharmacy, Clermont Ferrand, France
  • Footnotes
    Commercial Relationships  M. Doly, None; B. Bonhomme, None; C. Gamez, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 829. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Doly, B. Bonhomme, C. Gamez; Effect of EPO on isolated rat retina ERG b–wave amplitude. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):829.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The neuroprotective effect of erythropoietin (EPO) is now well established but this hematopoietic growth factor can also induce the release of neurotransmitters and so directly or indirectly influence neurotransmission. In order to assess the possible toxicity of EPO on retinal tissue, we investigated its effect on the retina electrophysiological function. Methods: Retinas from Wistar rats (250–300 g) were isolated and kept in a perfusion chamber under dim red light. Every 5 minutes, stimulation by a white light flash (300 lux, 1 ms) allowed to record electroretinograms (ERG). Epoetin alpha, the recombinant human form of EPO, was injected into the perfusion solution at a concentration of 80 UI/mL when the ERG b–wave becomes stable. ERGs were recorded during 5 hours after the injection and the b–wave amplitude was measured. Results: After EPO was applied to the retinas (n = 6), the b–wave amplitude curve versus time was the same as control ones (n = 6). At the studied concentration of 80 UI/mL, no statistical difference was shown neither on the b–wave amplitude evolution versus time nor on the retina survival length. It seems that a second concentration we tested (20 UI/mL) does not have any effect either. Conclusions: We showed no direct effect of high doses of EPO on the ERGs obtained from isolated rat retinas. Moreover, it is known now that EPO has a protective influence on apoptosis, inflammation and oxidation, all of them capable of damaging the retina. Thus EPO could be used to improve their deleterious consequences without any toxic effect on vision.

Keywords: retina • electroretinography: non–clinical • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×